There is one clinical trial.
The purpose of this study is to evaluate point of care SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test and correlate it with the standard method of testing in inpatients who have tested positive or negative for COVID19.
Description: Presence of IgG and/or IgM antibodies
Measure: IgG/IgM antibodies Time: from date of consent to date of test completion, up to 40 days